When patients were evaluated using laboratory criteria, the most common aPL antibody detected in both groups was LAC, which was positive in 65 (78.31%) patients in the APS group and 24 (21.82%) patients in the no-APS group (p < 0.001). The gene discussed is LCT; the disease is autoimmune polyendocrinopathy.